Safety Issues and Rationale for Neoadjuvant Approaches in Renal Cell Carcinoma

被引：3
作者：
Bessede, Thomas [2 ]
Pignot, Geraldine [1 ]
Patard, Jean-Jacques [2 ]
机构：
[1] Univ Paris 05, Cochin Hosp, Dept Urol, F-75014 Paris, France
[2] Univ Paris 11, Bicetre Hosp, Dept Urol, Le Kremlin Bicetre, France
来源：
EUROPEAN UROLOGY | 2011年 / 60卷 / 05期
关键词：
CYTOREDUCTIVE NEPHRECTOMY; SUNITINIB; THERAPIES; ERA;
D O I：
10.1016/j.eururo.2011.06.003
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：972 / 974
页数：3
相关论文
共 50 条
  • [21] Neoadjuvant Systemic Therapy in Localized and Locally Advanced Renal Cell Carcinoma
    Khaleel, Sari
    Jiang, Song
    Kotecha, Ritesh R.
    Hakimi, A. Ari
    FRONTIERS IN UROLOGY, 2022, 2
  • [22] A Review of Neoadjuvant Therapy for Localized and Locally Advanced Renal Cell Carcinoma
    Qin, Qian
    Tachibana, Isamu
    Margulis, Vitaly
    Cadeddu, Jeffrey A.
    Zhang, Tian
    CANCERS, 2025, 17 (02)
  • [23] Adjuvant and Neoadjuvant Therapies in High-Risk Renal Cell Carcinoma
    Smaldone, Marc C.
    Fung, Chunkit
    Uzzo, Robert G.
    Haas, Naomi B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (04) : 765 - +
  • [24] Management of non clear cell renal cell carcinoma: Current approaches
    Tsimafeyeu, Ilya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (01) : 5 - 13
  • [25] Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
    Bergerot, Paulo
    Lamb, Peter
    Wang, Evelyn
    Pal, Sumanta K.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12) : 2185 - 2193
  • [26] Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma
    Thomas, Anil A.
    Rini, Brian I.
    Lane, Brian R.
    Garcia, Jorge
    Dreicer, Robert
    Klein, Eric A.
    Novick, Andrew C.
    Campbell, Steven C.
    JOURNAL OF UROLOGY, 2009, 181 (02) : 518 - 523
  • [27] Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives
    Timsit, Marc-Olivier
    Albiges, Laurence
    Mejean, Arnaud
    Escudier, Bernard
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (12) : 1559 - 1569
  • [28] Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answers
    Homicsko, Krisztian
    Berthold, Dominik R.
    ANTI-CANCER DRUGS, 2011, 22 : S4 - S8
  • [29] Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma
    Christensen, Bryce R.
    Hajja, Yasmin M.
    Koshkin, Vadim
    Barata, Pedro C.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (02)
  • [30] Neoadjuvant Sorafenib Treatment of Clear Cell Renal Cell Carcinoma and Release of Circulating Tumor Fragments
    Kats-Ugurlu, Gursah
    Oosterwijk, Egbert
    Muselaers, Stijn
    Oosterwijk-Wakka, Jeannette
    Hulsbergen-van de Kaa, Christina
    de Weijert, Mirjam
    van Krieken, Han
    Desar, Ingrid
    van Herpen, Carla
    Maass, Cathy
    de Waal, Rob
    Mulders, Peter
    Leenders, William
    NEOPLASIA, 2014, 16 (03): : 221 - 228
12345